KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Charles River Laboratories International (CRL) over the last 16 years, with Dec 2024 value amounting to -$245.1 million.

  • Charles River Laboratories International's Cash from Investing Activities fell 58.02% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$192.6 million, marking a year-over-year increase of 52.71%. This contributed to the annual value of -$245.1 million for FY2024, which is 56.48% up from last year.
  • Charles River Laboratories International's Cash from Investing Activities amounted to -$245.1 million in FY2024, which was up 56.48% from -$563.2 million recorded in FY2023.
  • In the past 5 years, Charles River Laboratories International's Cash from Investing Activities registered a high of -$245.1 million during FY2024, and its lowest value of -$1.4 billion during FY2021.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$563.2 million (2023), whereas its average is -$472.1 million.
  • As far as peak fluctuations go, Charles River Laboratories International's Cash from Investing Activities slumped by 139.04% in 2021, and later soared by 57.72% in 2022.
  • Over the past 5 years, Charles River Laboratories International's Cash from Investing Activities (Yearly) stood at -$601.5 million in 2020, then slumped by 139.04% to -$1.4 billion in 2021, then surged by 57.72% to -$607.9 million in 2022, then grew by 7.36% to -$563.2 million in 2023, then skyrocketed by 56.48% to -$245.1 million in 2024.